A new Trichomonas vaginalis assay is now available. This test should be ordered in individuals suspected to be infected with Trichomonas vaginalis. View this post to watch a short three-minute video overview from Bobbi Pritt, M.D. and to view new test utilization pearls.
With the recent discovery of somatic calreticulin (CALR) mutations in the majority of essential thrombocythemia (ET) and primary myelofibrosis (PMF) patients lacking JAK2 or MPL mutations, Mayo Medical Laboratories now offers testing for the detection of CALR mutations.
The new CALR Mutation Analysis, Myeloproliferative Neoplasm (MPN) assay is now available to the Mayo Clinic practice and Mayo Medical Laboratories clients. This test should be ordered on patients with clinical suspicion of essential thrombocythemia or primary myelofibrosis.
Mayo Clinic and Mayo Medical Laboratories announce the launch of CANCP, a new gene panel cancer test to help tailor therapies to the individual patient based on the unique genomic signature of the patient’s tumor.
This new gene panel cancer test helps tailor therapies to the individual patient based on the unique genomic signature of the patient’s tumor. This test scans specific regions in 50 genes known to affect tumor growth and response to therapies. The test is now available to Mayo Clinic patients and to providers worldwide through Mayo Medical Laboratories.
This new Mayo Clinic assay provides clinicians an accurate measurement of serum thyroglobulin in patients with known or suspected anti-thyroglobulin autoantibodies or heterophilic antibodies. View a quick overview of the test's details and a five-minute video interview with Dr. Stefan Grebe.
Serum thyroglobulin testing using SISCAPA® technology and liquid chromatography, tandem mass spectrometry now performed at Mayo Medical Laboratories.
Mayo Medical Laboratories now offers testing for the detection of high-risk HPV (hrHPV), with genotyping for HPV-16 and HPV-18.
This new Mayo Clinic assay detects the 14 high-risk HPV types, and if present, provides specific genotype results for HPV-16 and/or HPV-18.
U.S. influenza activity remained high during the fourth week of 2014. However, the Mayo Clinic Virology Laboratory continues to see a decline in the percentage of outpatients presenting with an influenza-like illness.
Dr. Robin Patel, Division Chair of Clinical Microbiology, answers questions about Mayo Clinic's new KPC and NDM Surveillance PCR test.
In this introductory video to the series, Dr. Matt Binnicker discusses the symptoms of the flu, the flu season, and what trends we are seeing nationally, in Minnesota and at Mayo Clinic in Rochester.
David Murray, M.D., Ph.D., provides a brief overview of the new Alpha-1-Antitrypsin Proteotype S/Z by LC-MS/MS, Serum test now available from Mayo Medical Laboratories. This test should be ordered for individuals suspected of A1A deficiency and can be used for diagnosis and identification of a specific proteotype to determine prognosis.